Matthew Gline, CEO: Roivant Sciences ROIV Buy · Filed 25/09/18

Trade details

Type: Insider buy
Amount: $49,957.05
Shares · price: 3,315 sh · $15.07 a share
Held after: 17,287,081 sh
Stock: Roivant Sciences ROIV
Person: Matthew GlineCEO
Trade date: 25/09/18
Filed: 25/09/18
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: under 0.1%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 25/08/19~25/10/18

Matthew Gline's recent trades

Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/20
Traded 04/16
Matthew GlineCEO
Planned saleRoivant Sciences
Planned sale
Roivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/16
Traded 04/16
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$12.3M
566,116 sh
$12.3M
Filed 25/12/17
Traded 25/12/15
Matthew GlineCEO
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15